L
Lipeptides
Request Full Data Access to the PeptideMeter database of peptide tests.
Products
| Product | Rating | Count | Avg | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | A | 7 | 7.9 | 6.6 | 10.0 | 6 Dec 2025 |
| AA Water | X | 1 | 6.4 | 6.4 | 6.4 | 9 Jun 2025 |
| ACE-031 | X | 1 | 8.7 | 8.7 | 8.7 | 28 Mar 2025 |
| AHK-CU | X | 1 | 9.4 | 9.4 | 9.4 | 8 Jul 2025 |
| Anadrol Oil | X | 1 | 6.4 | 6.4 | 6.4 | 13 Jun 2025 |
| Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | X | 1 | 5.1 | 5.1 | 5.1 | 21 May 2025 |
| BPC157 10mg + TB500 10mg Blend | X | 1 | 7.5 | 7.5 | 7.5 | 25 Apr 2025 |
| Cardiogen | X | 1 | 8.6 | 8.6 | 8.6 | 8 Jul 2025 |
| Chonluten | X | 1 | 8.2 | 8.2 | 8.2 | 2 Jul 2025 |
| CJC-1295 With DAC | X | 1 | 7.4 | 7.4 | 7.4 | 27 Feb 2025 |
| CJC-1295 w/o DAC 10mg + IPA 10mg Blend | X | 1 | 10.0 | 10.0 | 10.0 | 24 Apr 2025 |
| Dianabol Oil | X | 1 | 7.4 | 7.4 | 7.4 | 16 Mar 2025 |
| DSIP | X | 1 | 8.6 | 8.6 | 8.6 | 17 Dec 2024 |
| EPO | X | 1 | 9.2 | 9.2 | 9.2 | 20 Jun 2025 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | X | 1 | 8.9 | 8.9 | 8.9 | 8 Jul 2025 |
| IGF-1 LR3 | X | 1 | 8.0 | 8.0 | 8.0 | 25 Apr 2025 |
| Immunological Enhancement (Glutathione 200mg+Ascorbic Acid 200mg+Zinc Sulfate 2.5mg) | X | 1 | 8.0 | 8.0 | 8.0 | 14 Jan 2025 |
| Ivermectin | X | 1 | 10.0 | 10.0 | 10.0 | 16 Mar 2025 |
| KPV Oral | X | 1 | 5.2 | 5.2 | 5.2 | 21 May 2025 |
| Lipo-B 216mg | X | 1 | 4.8 | 4.8 | 4.8 | 20 Jun 2025 |
| Lipo-C FAT BLASTER | X | 1 | 8.6 | 8.6 | 8.6 | 6 May 2025 |
| MENT (Trestolone Acetate) | X | 1 | 5.9 | 5.9 | 5.9 | 28 Mar 2025 |
| Methylene Blue | X | 1 | 5.6 | 5.6 | 5.6 | 2 Apr 2025 |
| MOTS-C | X | 1 | 9.1 | 9.1 | 9.1 | 17 Dec 2024 |
| NA Semax Amidate | X | 1 | 6.3 | 6.3 | 6.3 | 2 Apr 2025 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | X | 1 | 7.1 | 7.1 | 7.1 | 28 Mar 2025 |
| Nitroethane CAS 79-24-3 | X | 1 | 5.4 | 5.4 | 5.4 | 20 Jun 2025 |
| Oxytocin Acetate | X | 1 | 9.0 | 9.0 | 9.0 | 13 Jun 2025 |
| P-2-P (phenyl-2-propanone / BMK) CAS 103-79-7 | X | 1 | 7.9 | 7.9 | 7.9 | 13 Feb 2025 |
| PE 22-28 | X | 1 | 6.6 | 6.6 | 6.6 | 2 Apr 2025 |
| Prostamax | X | 1 | 10.0 | 10.0 | 10.0 | 2 Jul 2025 |
| Salbutamol | X | 1 | 6.0 | 6.0 | 6.0 | 2 Jul 2025 |
| Selank 10mg + Semax 10mg Blend | X | 1 | 6.6 | 6.6 | 6.6 | 28 Mar 2025 |
| Selank | X | 1 | 7.6 | 7.6 | 7.6 | 17 Dec 2024 |
| Semaglutide Raw | X | 1 | 9.0 | 9.0 | 9.0 | 8 Jul 2025 |
| Semax | X | 1 | 10.0 | 10.0 | 10.0 | 28 Mar 2025 |
| Super Human Blend (Arginine+Ornithine+Citrulline+Lysine+Glutamine+Proline+Taurine+Carnitine+NAC) | X | 1 | 8.9 | 8.9 | 8.9 | 13 Feb 2025 |
| Sustanon 250 | X | 1 | 9.6 | 9.6 | 9.6 | 28 Mar 2025 |
| Sustanon 400 | X | 1 | 10.0 | 10.0 | 10.0 | 24 Apr 2025 |
| Teriparatide | X | 1 | 5.6 | 5.6 | 5.6 | 21 May 2025 |
| Tesamorelin 11mg + Ipamorelin 6mg Blend | X | 1 | 7.8 | 7.8 | 7.8 | 2 Jul 2025 |
| Test Base (No Ester) | X | 1 | 7.8 | 7.8 | 7.8 | 11 Jun 2025 |
| TriTren 225 | X | 1 | 10.0 | 10.0 | 10.0 | 24 Apr 2025 |
| Vesugen | X | 1 | 7.3 | 7.3 | 7.3 | 16 Mar 2025 |
Test Results
| Date | Product | Score | Expected | Actual | Deviation | Purity | Lab |
|---|---|---|---|---|---|---|---|
| 25 May 2026 | AA Water | 5.5 | 20mg | 24.0mg | +19.8% | 95.53% | Lab F |
| 24 May 2026 | Lipo-B 216mg | 5.4 | 250mg/ml | 229.9mg/ml | -8.0% | 96.44% | Lab E |
| 24 May 2026 | Semaglutide Raw | 7.1 | 10g | 9.8g | -2.0% | 97.19% | Lab C |
| 24 May 2026 | MOTS-C | 9.0 | 10mg | 10.8mg | +7.8% | 97.22% | Lab C |
| 24 May 2026 | AHK-CU | 10.0 | 30mg | 26.5mg | -11.8% | 98.08% | Lab A |
| 24 May 2026 | MENT (Trestolone Acetate) | 8.1 | 300mg/ml | 328.4mg/ml | +9.5% | 96.91% | Lab E |
| 24 May 2026 | Anadrol Oil | 4.4 | 250mg/ml | 272.3mg/ml | +8.9% | 98.89% | Lab A |
| 24 May 2026 | KPV Oral | 4.8 | 25mg | 24.0mg | -3.9% | 99.90% | Lab A |
| 24 May 2026 | Immunological Enhancement (Glutathione 200mg+Ascorbic Acid 200mg+Zinc Sulfate 2.5mg) | 10.0 | 250mg/ml | 278.7mg/ml | +11.5% | 96.48% | Lab E |
| 24 May 2026 | Methylene Blue | 6.1 | 100mg | 89.4mg | -10.6% | 99.26% | Lab G |
| 23 May 2026 | Oxytocin Acetate | 9.0 | 15mg | 16.4mg | +9.1% | 99.03% | Lab A |
| 21 May 2026 | P-2-P (phenyl-2-propanone / BMK) CAS 103-79-7 | 9.7 | 1g | 1.0g | +0.1% | 97.34% | Lab B |
| 21 May 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 7.1 | 30mg | 29.3mg | -2.2% | 98.31% | Lab E |
| 20 May 2026 | Retatrutide | 8.0 | 5mg | 4.93mg | -1.4% | 99.90% | No Label / Silver Crimp / Blue Cap |
| 20 May 2026 | Prostamax | 9.6 | 20mg | 24.3mg | +21.6% | 97.21% | Lab A |
| 19 May 2026 | DSIP | 9.9 | 20mg | 21.7mg | +8.7% | 95.55% | Lab G |
| 17 May 2026 | Vesugen | 7.4 | 5mg | 5.4mg | +8.0% | 95.28% | Lab C |
| 29 Jan 2026 | Retatrutide | 6.6 | 5mg | 5.07mg | +1.4% | 99.31% | No Label / Silver Crimp / Blue Cap |
| 29 Jan 2026 | EPO | 7.8 | 50mg | 62.0mg | +24.1% | 98.41% | Lab E |
| 29 Jan 2026 | Nitroethane CAS 79-24-3 | 4.8 | 1g | 0.9g | -9.6% | 99.98% | Lab G |
| 29 Jan 2026 | PE 22-28 | 5.8 | 5mg | 4.7mg | -6.7% | 99.79% | Lab A |
| 26 Jan 2026 | Retatrutide | 7.8 | 15mg | 14.7mg | -2.0% | 99.80% | Silver Label / Copper Crimp / Clear Cap |
| 26 Jan 2026 | ACE-031 | 9.8 | 30mg | 34.5mg | +15.0% | 97.12% | Lab D |
| 26 Jan 2026 | Sustanon 400 | 8.4 | 100mg/ml | 122.6mg/ml | +22.6% | 96.03% | Lab F |
| 26 Jan 2026 | Teriparatide | 6.9 | 50mg | 48.5mg | -3.0% | 99.09% | Lab D |
| 26 Jan 2026 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 9.4 | 20mg | 23.4mg | +17.0% | 96.15% | Lab F |
| 19 Jan 2026 | Retatrutide | 10.0 | 5mg | 4.76mg | -4.8% | 99.95% | No Label / Silver Crimp / Blue Cap |
| 19 Jan 2026 | Super Human Blend (Arginine+Ornithine+Citrulline+Lysine+Glutamine+Proline+Taurine+Carnitine+NAC) | 9.2 | 300mg/ml | 321.6mg/ml | +7.2% | 99.68% | Lab E |
| 19 Jan 2026 | TriTren 225 | 8.9 | 300mg/ml | 323.6mg/ml | +7.9% | 96.22% | Lab A |
| 15 Jan 2026 | Retatrutide | 8.0 | 20mg | 19.4mg | -3.0% | 99.91% | No Label / Silver Crimp / Violet Cap |
| 9 Jan 2026 | Lipo-C FAT BLASTER | 9.4 | 100mg/ml | 85.1mg/ml | -14.9% | 98.69% | Lab C |
| 7 Jan 2026 | Retatrutide | 7.3 | 10mg | 10.2mg | +2.0% | 99.60% | No Label / Silver Crimp / Yellow Cap |
| 7 Jan 2026 | Semax | 10.0 | 2mg | 2.0mg | +0.0% | 97.42% | Lab A |
| 6 Jan 2026 | Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | 4.0 | 250mg/ml | 231.1mg/ml | -7.5% | 95.27% | Lab G |
| 6 Jan 2026 | Cardiogen | 7.3 | 2mg | 2.4mg | +22.2% | 95.82% | Lab F |
| 29 Dec 2025 | Test Base (No Ester) | 7.2 | 300mg/ml | 293.9mg/ml | -2.0% | 99.07% | Lab D |
| 12 Dec 2025 | CJC-1295 With DAC | 6.8 | 10mg | 9.3mg | -6.8% | 99.26% | Lab A |
| 12 Dec 2025 | Salbutamol | 6.4 | 20mg | 17.9mg | -10.7% | 97.49% | Lab B |
| 6 Dec 2025 | Retatrutide | 7.7 | 15mg | 15.4mg | +2.7% | 99.76% | Gray Label / Copper Crimp / Clear Cap |
| 5 Dec 2025 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 10.0 | 20mg | 23.4mg | +17.1% | 99.16% | Lab E |
| 5 Dec 2025 | Selank | 7.0 | 50mg | 45.8mg | -8.3% | 95.68% | Lab F |
| 23 Nov 2025 | NA Semax Amidate | 4.2 | 50mg | 61.0mg | +21.9% | 96.61% | Lab G |
| 17 Nov 2025 | BPC157 10mg + TB500 10mg Blend | 8.1 | 2mg | 2.0mg | +1.6% | 95.28% | Lab A |
| 17 Nov 2025 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 6.7 | 2mg | 2.4mg | +19.1% | 95.62% | Lab G |
| 14 Nov 2025 | Sustanon 250 | 9.2 | 250mg/ml | 285.7mg/ml | +14.3% | 95.30% | Lab F |
| 4 Nov 2025 | Chonluten | 6.2 | 50mg | 55.3mg | +10.6% | 95.22% | Lab E |
| 4 Nov 2025 | IGF-1 LR3 | 10.0 | 20mg | 19.4mg | -3.2% | 98.03% | Lab F |
| 9 Oct 2025 | Ivermectin | 9.3 | 10mg | 9.7mg | -3.0% | 97.46% | Lab E |
| 3 Oct 2025 | Dianabol Oil | 8.7 | 200mg/ml | 177.1mg/ml | -11.4% | 99.28% | Lab E |
| 3 Oct 2025 | Selank 10mg + Semax 10mg Blend | 6.5 | 15mg | 16.3mg | +8.7% | 98.27% | Lab C |